title: Limbic structures show altered glial-neuronal metabolism in the chronic phase of kainate induced epilepsy.
abstract: A better understanding is needed of how glutamate metabolism is affected in mesial temporal lobe epilepsy (MTLE). Here we investigated glial-neuronal metabolism in the chronic phase of the kainate (KA) model of MTLE. Thirteen weeks following systemic KA, rats were injected i.p. with [1-(13)C]glucose. Brain extracts from hippocampal formation, entorhinal cortex, and neocortex, were analyzed by (13)C and (1)H magnetic resonance spectroscopy to quantify (13)C labeling and concentrations of metabolites, respectively. The amount and (13)C labeling of glutamate were reduced in the hippocampal formation and entorhinal cortex of epileptic rats. Together with the decreased concentration of NAA, these results indicate neuronal loss. Additionally, mitochondrial dysfunction was detected in surviving glutamatergic neurons in the hippocampal formation. In entorhinal cortex glutamine labeling and concentration were unchanged despite the reduced glutamate content and label, possibly due to decreased oxidative metabolism and conserved flux of glutamate through glutamine synthetase in astrocytes. This mechanism was not operative in the hippocampal formation, where glutamine labeling was decreased. In neocortex labeling and concentration of GABA were increased in epileptic rats, possibly representing a compensatory mechanism. The changes in the hippocampus might be of pathophysiological importance and merit further studies aiming at resolving metabolic causes and consequences of MTLE.
authors: Department of Neuroscience, Norwegian University of Science and Technology (NTNU), MTFS, Trondheim 7489, Norway.
authors: Silje
authors: S
authors: Alvestad
authors: Janniche
authors: J
authors: Hammer
authors: Elvar
authors: E
authors: Eyjolfsson
authors: Hong
authors: H
authors: Qu
authors: Ole Petter
authors: OP
authors: Ottersen
authors: Ursula
authors: U
authors: Sonnewald
mesh_terms: D000818:Animals; D002247:Carbon Isotopes; D002908:Chronic Disease; D004827:Epilepsy / Q000139:chemically induced / Q000378:metabolism*; D007608:Kainic Acid / Q000633:toxicity*; D008032:Limbic System / Q000378:metabolism*; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D009457:Neuroglia / Q000378:metabolism*; D009474:Neurons / Q000378:metabolism*; D011522:Protons; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D002247:Carbon Isotopes; D011522:Protons; D007608:Kainic Acid
references: J Cereb Blood Flow Metab. 2005 Oct;25(10):1254-64
references: 15902201
references: Neurochem Int. 2006 May-Jun;48(6-7):498-507
references: 16542760
references: Neuroscience. 1983;8(2):299-315
references: 6843825
references: Nature. 1983 Feb 10;301(5900):517-20
references: 6130475
references: J Neurochem. 1995 Jun;64(6):2773-82
references: 7760058
references: Curr Drug Metab. 2005 Apr;6(2):127-39
references: 15853764
references: J Neurochem. 1993 Feb;60(2):395-407
references: 8419527
references: Lancet. 2004 Jan 3;363(9402):28-37
references: 14723991
references: Neuroimage. 2006 Aug 15;32(2):684-95
references: 16762567
references: Prog Neurobiol. 1990;35(4):245-96
references: 1980745
references: J Cereb Blood Flow Metab. 2007 Apr;27(4):811-20
references: 17033695
references: J Neurosci. 1989 Jul;9(7):2562-74
references: 2501460
references: Brain Res. 1979 Feb 2;161(2):303-10
references: 31966
references: J Neurosci. 1995 Oct;15(10):6301-13
references: 7472396
references: Exp Neurol. 1990 Sep;109 (3):333-41
references: 2209775
references: Can J Physiol Pharmacol. 1972 Aug;50(8):740-52
references: 5053785
references: Electroencephalogr Clin Neurophysiol. 1972 Mar;32(3):281-94
references: 4110397
references: Brain Res. 1985 Mar 11;329(1-2):364-7
references: 3884090
references: Epilepsia. 2000;41 Suppl 6:S144-52
references: 10999536
references: Epilepsy Behav. 2005 Sep;7(2):190-203
references: 16098816
references: Epilepsy Res. 1998 Jun;31(1):73-84
references: 9696302
references: J Cereb Blood Flow Metab. 1990 Sep;10(5):748-57
references: 2384546
references: J Neurosci Res. 2001 Dec 1;66(5):951-8
references: 11746423
references: Neuroscience. 1988 Aug;26(2):379-85
references: 2902535
references: Lancet. 1993 Jun 26;341(8861):1607-10
references: 8099987
references: Neuroscience. 1983 Dec;10(4):1301-15
references: 6141539
references: Epilepsy Res. 1999 Jul;35(3):211-7
references: 10413316
references: NMR Biomed. 2003 Oct-Nov;16(6-7):424-9
references: 14679504
references: Epilepsia. 2002 Jul;43(7):703-10
references: 12102672
references: Brain Res. 2000 Jan 10;852(2):255-62
references: 10678750
references: J Cereb Blood Flow Metab. 2004 Sep;24(9):1004-14
references: 15356421
references: Neurology. 1995 Jan;45(1):123-6
references: 7824101
references: Epilepsia. 1992;33 Suppl 5:S3-12
references: 1330509
references: Neuroscience. 1997 Dec;81(3):847-60
references: 9316033
references: Neurosci Lett. 2000 Feb 4;279(3):169-72
references: 10688056
references: Ann Neurol. 1996 Dec;40(6):908-11
references: 9007096
references: Biochem J. 1990 Feb 15;266(1):133-9
references: 1968742
references: Neurochem Int. 2003 Jan;42(1):101-6
references: 12441174
references: Exp Neurol. 2001 Feb;167(2):227-41
references: 11161611
references: Prog Neurobiol. 1995 Dec;47(6):477-511
references: 8787032
references: Neurology. 1993 Mar;43(3 Pt 1):589-94
references: 8095715
references: Neuroscience. 1985 Feb;14(2):375-403
references: 2859548
references: Epilepsia. 2002 Apr;43(4):325-35
references: 11952761
references: Neuroscience. 1985 Nov;16(3):589-606
references: 2869443
references: Neuroscience. 1984 Dec;13(4):1073-94
references: 6527790
references: Neurosignals. 2004 Nov-Dec;13(6):290-7
references: 15627816
references: Neuroscience. 1980;5(3):515-28
references: 6892841